Orphan Reach confirms acquisition by Emmes, a US-based global, full-service CRO
May 17, 2021
Emmes launches Orphan Reach™: Emmes’ Rare Disease Center
November 3, 2021
Emmes is excited to be attending the World Orphan Drug Congress USA 2021, from August 25th – 27th in Oxon Hill, MD USA
The World Orphan Drug Congress USA is dedicated to the opportunities and challenges for commercialization and market potential for drugs to treat rare diseases.
Our attendees will include staff such as our Chief Research Officer, Chief Business Officer, Associate VP of Program Management Office, and Associate Director of Marketing & Communications.
You can schedule a meeting with Emmes to discuss Orphan Reach, Emmes’ Rare CRO: a dedicated division for the advancement of rare disease research and specialized clinical trial design.
Click here to schedule a meeting >
We look forward to seeing you!
